Nisoldipine
From Self-sufficiency
Revision as of 17:13, 29 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s))
| File:Nisoldipine.svg | |
| Systematic (IUPAC) name | |
|---|---|
|
isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | |
| Clinical data | |
| Pregnancy category |
|
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Protein binding | 99% |
| Biological half-life | 7-12 hours |
| Identifiers | |
| CAS Number | 63675-72-9 |
| ATC code | C08CA07 (WHO) |
| PubChem | CID 4499 |
| DrugBank | APRD00635 |
| Chemical data | |
| Formula | C20H24N2O6 |
| Molar mass | 388.414 g/mol[[Script error: No such module "String".]] |
| (verify) | |
Nisoldipine (INN) is a calcium channel blocker of the dihydropyridine class. It sold in the United States under the proprietary name Sular.
External links
- DDB 30009
- Mielcarek J, Grobelny P, Szamburska O (2005). "The effect of beta-carotene on the photostability of nisoldipine". Methods Find Exp Clin Pharmacol. 27 (3): 167–71. doi:10.1358/mf.2005.27.3.890873. PMID 15834448.
- Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
- Hamilton S, Houle L, Thadani U (1999). "Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure". Heart Dis. 1 (5): 279–88. PMID 11720635.
| 30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- CS1 maint: Multiple names: authors list
- Calcium channel blockers
- Pyridines
- Carboxylate esters
- Nitro compounds
- Cardiovascular system drug stubs
- 2Fix
